Related Experiment Videos
[Hypereosinophilic syndrome]
1Department of Hematology, Showa University.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|March 1, 1993
Summary
This review of hypereosinophilic syndrome (HES) cases shows varied presentations, from mild edema to severe vascular and organ involvement. Treatment should be individualized based on HES severity and associated conditions.
Area of Science:
- Hematology
- Internal Medicine
- Pathology
Context:
- Hypereosinophilic syndrome (HES) is a group of disorders characterized by persistent eosinophilia.
- Understanding the diverse clinical manifestations and underlying mechanisms of HES is crucial for effective management.
- Recent advancements have highlighted HES as a common factor in various disease variants.
Purpose:
- To review ten cases of hypereosinophilic syndrome (HES) that met specific diagnostic criteria.
- To delineate the spectrum of HES presentations, including mild and severe forms.
- To evaluate current treatment approaches for HES based on clinical presentation.
Summary:
- Reviewed ten hypereosinophilic syndrome (HES) cases, identifying mild forms with edema and severe forms with vascular, lung, and heart complications.
- Mild HES may not require treatment, while severe forms often respond to high-dose prednisolone.
- The evolving understanding of HES, linked to a common hypereosinophilic factor across disease variants, marks a significant conceptual shift.
Impact:
- Highlights the importance of individualized treatment strategies for hypereosinophilic syndrome (HES).
- Emphasizes the need for accurate diagnosis to differentiate HES subtypes and guide therapy.
- Contributes to a refined understanding of HES, facilitating better patient outcomes through tailored interventions.